Abbott Laboratories ABT

101.29 0.22 0.22% as of 25 Sep
Market cap
$174.8B
P/E
32.8×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

30.62% 12.96% 12.33% 10.58%
ROA
17.63% 7.76% 6.54% 5.62%
ROIC
8.54% 8.87% 6.06% 5.83%
Return on Tangible Assets
64.23% 30.61% 32.17% 27.80%
Average Days of Receivables
67.75 65.29 66.39 67.37
Free Cash Flow per Share
3.97 4.25 4.23 4.50
Free Cash Flow
6,917.00 7,395.00 7,378.00 7,824.00
Capital Expenditures
(2,202.00) (2,171.00) (2,086.00) (2,081.00)
Piotroski F-Score
6.00 5.00 4.00 4.00
Other line items
Cash ROIC
12.68% 12.82% 10.06% 11.01%
Accounts Receivable Turnover
5.77 5.97 5.81 5.62
Accounts Payable Turnover
4.74 4.58 4.44 4.44
Inventory Turnover
2.86 3.05 2.90 2.83
Average Days of Payables
77.82 80.11 86.51 86.57
Days of Inventory on Hand
126.61 122.58 129.22 132.10
Tax Rate
0.72 (0.23) (0.23) (0.28)
Research and Development Expense of Revenue
6.74% 6.64% 6.63% 6.78%
Selling, General and Administrative Expense of Revenue
27.62% 27.82% 28.83% 29.93%
Share Based Compensation of Revenue
1.51% 1.50% 1.53% 1.54%
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
0.65 1.47 1.51 1.83
Depreciation/Fixed assets
0.27 0.26 0.26 0.27
Capex/Depreciation
(0.70) (0.70) (0.66) (0.60)
Revenue per Share
25.17 25.46 25.90 26.77
Operating CF per Share
5.23 5.49 5.43 5.69
Capex per Share
(1.26) (1.25) (1.20) (1.20)
Capex to Sales
0.05 0.05 0.05 0.04
Net Profit Margin
31.88% 14.72% 13.91% 11.65%

Fold the line items

Columns are period end dates